Ascendis Pharma A/S (ASND) vs Exelixis, Inc. (EXEL)
Ascendis Pharma A/S and Exelixis, Inc. are both Biotechnology companies. Ascendis Pharma A/S and Exelixis, Inc. are of similar size ($15.7B and $14.4B). Ascendis Pharma A/S trades at the lower P/E: 16.3× against 17.6×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 9.23%. Ascendis Pharma A/S has the higher net margin (71.2% vs 35.3%) and the lower return on invested capital (15.1% vs 60.5%). Across the 22 metrics below, Exelixis, Inc. leads on 14 and Ascendis Pharma A/S on 8.
Valuation
Profitability
| Metric | ASND | EXEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 96.48% | 65.16% |
| Operating margin | 24.84% | 39.88% | 0.00% |
| Net margin | 71.20% | 35.33% | 0.00% |
| Free cash flow margin | 31.97% | 47.55% | 0.00% |
| Return on equity | 118.44% | 44.39% | (57.72%) |
| Return on assets | 44.34% | 33.28% | (49.22%) |
| Return on invested capital | 15.07% | 60.45% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack